News Focus
News Focus
Followers 202
Posts 9949
Boards Moderated 7
Alias Born 10/02/2010

Re: soak post# 17828

Wednesday, 06/06/2018 1:19:28 AM

Wednesday, June 06, 2018 1:19:28 AM

Post# of 21373
Lets shatter a trading myth and expand on your post.

Public companies are allowed to divulge insider information to investors who have substantial positions in the company, contrary to popular belief.

It is the responsibility of those investors to not trade or publically share insider information until made public.

For these investors to agree to those terms hints that ONCX FDA progress may be positive.

If ONCX releases positive news about the second dosing group, you have deep pockets able to then participate in open market purchases.

We could then see a few SC -13G filings, which would confirm what most of us suspect.

ONCX is real company, with a real chance, to bring a viable Cancer treatment to market.

No wonder the Susan G. Komen Foundation provided early grants for Prolanta development.

IMO and FWIW.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today